Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1148020150400030093
Á¶¼±´ëÇб³ÀÇ´ë³í¹®Áý
2015 Volume.40 No. 3 p.93 ~ p.100
Prognostic Factors Related to The Duration of Fever after Macrolides Treatment in Children with Mycoplasma pneumoniae Pneumonia
Lee Jae-Sung

Lee Ki-Kang
Kim Yong-Wook
Kim Kyoung-Sim
Kim Eun-Young
Kim Young
Jang Hae-In
Cho Hyoung-Min
Abstract
The present study aimed to identify the factors that can clinically predict responses to macrolides treatment in patients with Mycoplasma pneumoniae pneumonia. Of the patients admitted to the pediatrics department of Kwangju Christian Hospital during December 2012 to March 2015, 195 patients who had pneumonia according to findings of chest radiography, positive Mycoplasma IgM, and fever at the time of admission were selected as study subjects. Patients were divided into one group wherein the duration of fever after macrolides treatment was 3 days or less and another group wherein the duration of fever was 4 days or more (169 patients [86.7%] vs 26 patients [13.3%]). In the group with fever duration of 4 days or more, a greater number of patients had a history of atopic dermatitis (3.6% vs 15.4%, p=0.11), and the symptom duration before admission was longer (cough: 4.04 days vs 6.38 days, p<0.001; fever: 3.96 days vs 6.08 days, p<0.001). Moreover, according to laboratory test results in the group with fever duration of 4 days or more, LDH levels were high (648.16 IU/L vs 829.92 IU/L, p=0.001), and there was a significant correlation between LDH levels and the duration of fever after macrolides treatment.
KEYWORD
Mycoplasma pneumoniae pneumonia, Children, Atopic dermatitis, LDH, Steroid
FullTexts / Linksout information
Listed journal information